Pharmaceutical earnings rise
India’s pharmaceuticals company Gufic Biosciences reported higher revenue and net profit for July–September. The consolidated results approved on November 14 cover the quarter ended September 30. The group reports its activities within a single pharmaceuticals segment.[1], [2]
Quarterly operating revenue increased from 23,705.45 lakh Indian rupees to 28,827.30 lakh rupees. One lakh equals 100,000 rupees. Profit from continuing operations rose from 1,682.26 lakh rupees to 2,346.86 lakh rupees. Half-year revenue was 54,909.10 lakh rupees, with profit from continuing operations of 4,578.14 lakh rupees.[1]
